Prospective Surveillance for Breast Cancer-Related Lymphedema

Summary

This randomized trial will test the effect of a prospective surveillance program for early detection and subclinical management of breast cancer-related lymphedema on the prevalence of chronic lymphedema.

Eligibility

Inclusion Criteria:

* female;
* ≥18 years;
* surgery for breast cancer (unilateral and bilateral) including ALDN with \>6 lymph nodes removed;
* can effectively communicate verbally in Danish;

Exclusion Criteria:

* surgery for breast cancer with SLNB or \< 6 nodes removed;
* pre-existing lymphedema (primary or secondary);
* previous treatment for breast cancer;
* pace maker;
* conditions known to cause swelling (pregnancy, congestive heart failure, chronic/acute renal disease, cor pulmonale, nephrotic syndrome, nephrosis, liver failure or cirrhosis, pulmonary edema, and thrombophlebitis or deep vein thrombosis in the arms).

Conditions2

Browse More Trials